ExCPT Pharmacy Technician Practice Exam 2026 – Complete Prep Resource

Isotretinoin, a potent medication used primarily for severe acne, is associated with the iPLEDGE program. This is a risk management strategy aimed at preventing fetal exposure to isotretinoin due to its high teratogenic potential. The iPLEDGE program requires patients, providers, and pharmacies to comply with specific guidelines to ensure safe use of the medication.

Participants must be registered in the iPLEDGE program to prescribe, dispense, or receive isotretinoin, which involves confirming patient status regarding pregnancy and adherence to effective contraception. This program is essential in mitigating the risks associated with isotretinoin and is closely monitored by the manufacturer and regulatory bodies.

Other programs mentioned, such as RevAssist, STEPS, and TOUCH, are associated with different medications or treatments and do not pertain to isotretinoin. RevAssist is related to the medication Revlimid, which is used for certain types of cancer; STEPS is associated with the drug thalidomide; and TOUCH applies to pregnancy prevention in patients receiving elosulfase alfa or similar therapies. Thus, the correct association between isotretinoin and the iPLEDGE program highlights the importance of adherence to safety protocols in managing medications with significant